3 Indian drugmakers sign agreement with Gilead Sciences, US to produce and sell Remdesivir

indica News Bureau- Gilead Sciences, the US drug maker has signed a non-exclusive voluntary licensing agreements with three Indian pharmaceutical companies — Hyderabad-based Hetero Labs, Mumbai-headquartered Cipla, and Noida-based Jubilant Life Sciences to manufacture and sell the anti-viral drug to people who have severe COVID-19 infection. US-based Mylan which has a strong base in India […]